E-LIB Suche - Ergebnisse für: Galetta, D.

1

52P Liquid biopsy monitoring in BRAF V600E mutated NSCLC pa..:

Leonetti, A. ; Minari, R. ; Pluchino, M....
ESMO Open. 9 (2024) - p. 102631 , 2024

Link: https://doi.org/10.1016/..

2

53P MET exon 14 skipping mutations in non-small cell lung c..:

Reale, M.L. ; Passiglia, F. ; Cappuzzo, F....
ESMO Open. 9 (2024) - p. 102632 , 2024

Link: https://doi.org/10.1016/..

3

A cross-sectional study evaluating the exercise discussion ..:

Avancini, A. ; Giannarelli, D. ; Borsati, A....
ESMO Open. 9 (2024) 7 - p. 103624 , 2024

Link: https://doi.org/10.1016/..

4

EP04.01-02 Volatile Organic Compounds in Exhaled Breath as ..:

Catino, A. ; Di Gilio, A. ; Nisi, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S454 , 2023

Link: https://doi.org/10.1016/..

5

LBA2 First-line (1L) durvalumab (D) + platinum-etoposide (E..:

Reinmuth, N. ; Özgüroğlu, M. ; Leighl, N.B....
Immuno-Oncology and Technology. 20 (2023) - p. 100692 , 2023

Link: https://doi.org/10.1016/..

6

EP06.03-18 Atlas: Italian Knowledge Based Database for Biom..:

Malapelle, U. ; Pepe, F. ; Passiglia, F....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S490 , 2023

Link: https://doi.org/10.1016/..

7

Randomized open-label controlled study of cancer vaccine OS..:

Besse, B. ; Felip, E. ; Garcia Campelo, R....
Annals of Oncology. 34 (2023) 10 - p. 920-933 , 2023

Link: https://doi.org/10.1016/..

8

EP01.01-12 Binge-Watching Frequency and Tobacco Use in Adol..:

Bafunno, D. ; Galetta, D. ; Catino, A....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S418 , 2023

Link: https://doi.org/10.1016/..

9

92P Predictors, surrogate and patient-reported outcomes in ..:

Bertolaccini, L. ; Mohamed, S. ; Galetta, D....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S94-S95 , 2023

Link: https://doi.org/10.1016/..

10

MA07.09 Adapted Physical Activity (AMAti) Program for Lung ..:

Vallone, S. ; Carnio, S. ; Mirandola, D....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S124 , 2023

Link: https://doi.org/10.1016/..

11

P2.10-05 Circulating CD3+CD56+ Cells as a Biomarker for Imm..:

longo, V. ; negri, A. ; De Summa, S....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S147-S148 , 2022

Link: https://doi.org/10.1016/..

12

EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgicall..:

Leonetti, A. ; Minari, R. ; Boni, L....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S231 , 2022

Link: https://doi.org/10.1016/..

13

EP08.02-101 Real-world Data from KRAS-mutant Advanced NSCLC..:

Bungaro, M. ; Garbo, E. ; Jacobs, F....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S449 , 2022

Link: https://doi.org/10.1016/..

14

EP08.02-048 Crizotinib in ROS1+NSCLC: Long-term OS Analysis..:

Cappuzzo, F. ; Chiari, R. ; Tiseo, M....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S421 , 2022

Link: https://doi.org/10.1016/..

15

EP16.03-040 Biomarkersatlas.com: the Italian NSCLC Precisio..:

Malapelle, U. ; Pepe, F. ; Pisapia, P....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S607-S608 , 2022

Link: https://doi.org/10.1016/..